vasoactive-intestinal-peptide and Pre-Eclampsia

vasoactive-intestinal-peptide has been researched along with Pre-Eclampsia* in 1 studies

Other Studies

1 other study(ies) available for vasoactive-intestinal-peptide and Pre-Eclampsia

ArticleYear
Increased plasma levels of vasoactive intestinal polypeptide in pre-eclampsia.
    British journal of obstetrics and gynaecology, 1991, Volume: 98, Issue:8

    To investigate the plasma vasoactive peptide (VIP) levels in pregnancies complicated by pre-eclampsia.. A prospective clinical study.. University Department of Obstetrics, Tromsø, Norway.. 18 women with untreated gestational proteinuric hypertension between 32 and 40 weeks gestation (13 primigravid) and 8 women with normal pregnancies of similar gestational age.. Fasting blood samples on two occasions, 10 min apart.. Plasma VIP measured by radioimmunoassay.. Mean maternal plasma VIP was 13.9 (SEM 1.7) pmol/l in those with pre-eclampsia and 4.4 (SEM 0.5) pmol/l in normal pregnancies (P less than 0.0001).. The increased levels of VIP in pre-eclampsia may represent a powerful compensatory mechanism to restore vascular perfusion of various organs, including the uterus and placenta.

    Topics: Adolescent; Adult; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Vasoactive Intestinal Peptide

1991